Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Sankyo Co. Ltd.](/topic/$6417t)

### Top News

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"AstraZeneca and Gilead Report New Data in Triple-Negative Breast Cancer Race - Bloomberg"  
[News Link](https://www.bloomberg.com/news/articles/2025-10-20/astrazeneca-and-gilead-report-new-data-in-triple-negative-breast-cancer-race) [@business](/creator/x/business) 2025-10-20T10:22Z 208.1M followers, 20.2K engagements


"AstraZeneca and Daiichis Enhertu Shows Promise in Early Breast Cancer Treatment - Bloomberg"  
[News Link](https://www.bloomberg.com/news/articles/2025-10-20/astrazeneca-and-daiichi-s-enhertu-shows-promise-in-early-breast-cancer-treatment) [@business](/creator/x/business) 2025-10-20T05:58Z 208.1M followers, 22.1K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Sankyo Co. Ltd.

Top News

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"AstraZeneca and Gilead Report New Data in Triple-Negative Breast Cancer Race - Bloomberg"
News Link @business 2025-10-20T10:22Z 208.1M followers, 20.2K engagements

"AstraZeneca and Daiichis Enhertu Shows Promise in Early Breast Cancer Treatment - Bloomberg"
News Link @business 2025-10-20T05:58Z 208.1M followers, 22.1K engagements

Sankyo Co. Ltd.
/topic/$6417t/news